VIYASH vs WOCKPHARMA: Stock Comparison

Viyash Scientific Ltd vs Wockhardt Ltd

Live data: 22 July 2026, 3:03 PM IST • Source: NSE and company filings

Wockhardt Ltd is the larger company by market capitalisation. Viyash Scientific Ltd shows a lower P/E, a higher ROE and lower leverage, while Wockhardt Ltd shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Viyash Scientific Ltd and Wockhardt Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, VIYASH is more favourable on 7 of 13 scored metrics and WOCKPHARMA on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
WOCKPHARMA is the larger company
₹30,362 Cr vs ₹11,242 Cr
P/E Ratio
VIYASH has a lower P/E
65.27x vs 144.46x
P/B Ratio
VIYASH has a lower P/B
3.98x vs 6.23x
EPS
WOCKPHARMA has higher earnings per share
₹13.1 vs ₹4.06
Revenue Growth (TTM YoY)
WOCKPHARMA has faster revenue growth
26% vs 0%
Qtr Sales Growth
VIYASH has stronger quarterly sales growth
129% vs 29.9%
Qtr Profit Growth
WOCKPHARMA has stronger quarterly profit growth
688% vs 455%
ROE
VIYASH has a higher ROE
11% vs 6.11%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricVIYASHWOCKPHARMA
SectorHealthcare
IndustryPharmaceuticals

Price

MetricVIYASHWOCKPHARMA
Live Price₹257₹1,864.4
Day Change-3.07%-1.68%
Volume11.15 L7.23 L
52-Week High₹298₹2,422.3
52-Week Low₹178.13₹1,086.7
Distance from 52W High-13.76%-23.03%

Valuation

MetricVIYASHWOCKPHARMA
Market Cap₹11,242 Cr₹30,362 Cr
P/E Ratio65.27x144.46x
P/B Ratio3.98x6.23x
EPS₹4.06₹13.1
Book Value₹66.6₹304
Dividend Yield0%0%

Growth

MetricVIYASHWOCKPHARMA
Revenue Growth (TTM YoY)0%26%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth129%29.9%
Qtr Profit Growth455%688%

Profitability & Leverage

MetricVIYASHWOCKPHARMA
ROE11%6.11%
ROCE19%7.55%
Net Margin6.57%3.3%
Operating Margin19.1%19.3%
Debt to Equity0.17x0.45x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricVIYASHWOCKPHARMA
Promoter Holding0%49.08%
FII Holding2.94% 0.22 pp7.09% 0.1 pp
DII Holding7.99% 0.63 pp10.96% 0.41 pp
Public Holding27.67% 0.3 pp32.83% 0.52 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Viyash Scientific Ltd and Wockhardt Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.